• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human E3 ubiquitin-protein ligase UBR3 (UBR3), Truncated

ACP06045

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP06045 Target NameUBR3
FormLyophilized powderExpression SystemCustom Production. Please inquire and provide the desire expression system.
Protein LengthPartialPurity>85% (SDS-PAGE)
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ6ZT12
Background Information
  • Uniprot Id

    Q6ZT12

  • Target Species

    Human

  • Target Name

    UBR3

  • Target Full Name

    E3 ubiquitin-protein ligase UBR3

  • Target Function

    E3 ubiquitin-protein ligase which is a component of the N-end rule pathway. Does not bind to proteins bearing specific N-terminal residues that are destabilizing according to the N-end rule, leading to their ubiquitination and subsequent degradation. May play a role in Shh signaling by mediating the ubiquitination of Kif7. May be important for MYH9 function in certain tissues, possibly by regulating the ubiquitination of MYH9 and consequently affecting its interaction with MYO7A.

  • Target Subcellular Location

    Membrane; Multi-pass membrane protein.

  • Target Protein Families

    UBR1 family

  • Target Synonyms

    DKFZp434P117; DKFZp686N10185; E3 ubiquitin-protein ligase UBR3; FLJ37422; KIAA2024; MGC126489; N-recognin-3; Ubiquitin-protein ligase E3-alpha-3; Ubiquitin-protein ligase E3-alpha-III; Ubr3; UBR3_HUMAN; Zinc finger protein 650; ZNF 650; ZNF650

Inquire Recombinant Human E3 ubiquitin-protein ligase UBR3 (UBR3), Truncated Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification